Summary & Overview
HCPCS C9088: Instillation of bupivacaine and meloxicam, 1 mg/0.03 mg
HCPCS Level II code C9088 represents the instillation of a combination product containing bupivacaine and meloxicam (1 mg/0.03 mg) for localized pain control and anti-inflammatory effect. The code captures a specific drug-administration service that can affect perioperative and procedural analgesia strategies, and its use has implications for facility billing, pharmacy preparation, and clinical workflows. Nationally, codes for instilled local analgesic-NSAID combinations are relevant to outpatient surgery centers, ambulatory procedure units, and clinics managing acute procedural pain.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and payment policies across these payers influence coding practices, site-of-service billing, and formulary positioning for combination instillation products.
Readers will find a concise summary of what C9088 denotes clinically and operationally, plus context on payer coverage patterns, coding and billing considerations, common modifiers, and where this service is typically delivered. The publication also highlights benchmarking elements, potential policy updates affecting administration and reimbursement, and clinical context surrounding use of combined local anesthetic and NSAID instillations. Data not available in the input will be identified explicitly in the detailed sections.
Billing Code Overview
HCPCS Level II code C9088 describes an instillation of a fixed-dose combination medication containing bupivacaine and meloxicam (1 mg/0.03 mg). This service denotes the administration of the specified local anesthetic and nonsteroidal anti-inflammatory agent formulation by instillation, intended for localized pain control and anti-inflammatory effect.
-
Service type: Instillation of a local anesthetic/NSAID combination
-
Typical site of service: Ambulatory procedure areas, outpatient surgical centers, or clinic treatment rooms where localized instillation procedures are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting for a localized intraoperative or postoperative analgesia procedure where an instillation of a combined local anesthetic and NSAID formulation is indicated. The service C9088 (instillation, bupivacaine and meloxicam, 1 mg/0.03 mg) is provided during or immediately after a surgical procedure such as outpatient knee arthroscopy, shoulder arthroscopy, small open orthopedic procedures, or soft-tissue surgery to provide extended local analgesia and reduce systemic opioid requirement. The workflow usually includes preoperative consent and documentation of indication, sterile preparation of the wound or joint space by the operating surgeon or qualified proceduralist, instillation of the specified product into the surgical field or joint space prior to closure, and documentation of the drug name, HCPCS code C9088, dosage administered, lot number, and site of instillation in the operative note. Post-procedure monitoring for expected analgesic effect and potential adverse reactions (local anesthetic toxicity, bleeding, or NSAID-related reactions) is documented in the recovery record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the instillation requires substantially greater effort, time, or complexity than typical and documentation supports the increased resource use. |